Aerovate Therapeutics, Inc.

NASDAQ:AVTE

2.68 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 44.2233.75131.11531.0699.12223.49132.1860.90126.57122.39722.41927.45728.13754.197180.87859.158.6414.573-3.514
Short Term Investments 31.9944.87257.61573.13390.21298.948103.01989.19592.358106.823120.159124.531132.935113.17800007.028
Cash and Short Term Investments 76.2178.62388.73104.20299.334122.439135.199150.096118.929129.22142.578151.988161.072167.375180.87859.158.6414.5733.514
Net Receivables 0000000000000000000
Inventory 0000000000000000000
Other Current Assets 1.1631.4941.8756.5583.9051.7932.4042.3741.642.2762.5781.4614.8136.9584.4480.3180.9630.1030
Total Current Assets 77.37380.11790.605110.76103.239124.232137.603152.47120.569131.496145.156153.449165.885174.333183.10259.3099.6044.6763.514
Non-Current Assets:
Property, Plant & Equipment, Net 0.160.2150.2730.8530.9850.9021.0291.0561.1751.2451.4241.5040.7870.7280.7450.0350.0370.0390
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 0000000000000000000
Long Term Investments 0000000000000000000
Tax Assets 0000000000000000000
Other Non-Current Assets 000.0810.0812.5972.2842.2442.2292.6492.561.0760.7310.3270.3020.2783.090.3070-3.514
Total Non-Current Assets 0.160.2150.3540.9343.5823.1863.2733.2853.8243.8052.52.2351.1141.031.0233.1250.3440.039-3.514
Total Assets 77.53380.33290.959111.694106.821127.418140.876155.755124.393135.301147.656155.684166.999175.363184.12562.4349.9484.7150
Liabilities & Equity:
Current Liabilities:
Account Payables 0.0690.2240.9084.1793.3132.3963.5045.5294.7262.5754.5412.0682.8631.2082.5463.0331.5410.6120
Short Term Debt 0.3120.4170.4590.950.4450.840.9020.7580.3730.3850.7580.6940.3860.3840.1470000
Tax Payables 0000000000000000000
Deferred Revenue 00000010.3316.793000001.0070.9430000
Other Current Liabilities 2.0363.1878.94811.89111.7614.40110.3196.9975.5384.8222.4060.9941.4540.9581.1321.160.2411.1620
Total Current Liabilities 2.4173.82810.31517.0215.51817.63714.72513.28410.6377.7827.7053.7564.7032.553.8254.1931.7821.7740
Non-Current Liabilities:
Long Term Debt 000.0810.2060.3290.2550.3580.4760.5910.7050.80.0130.0140.3820.4520000
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities 0.070.070.070.070.070.070.070.0690.070.0710.0130.8620.3350.0130024.28116.2850
Total Non-Current Liabilities 0.070.070.1510.2760.3990.3250.4280.5450.6610.7760.8130.8750.3490.3950.45279.81924.28116.2850
Total Liabilities 2.4873.89810.46617.29615.91717.96215.15313.82911.2988.5588.5184.6315.0522.9454.27784.01226.06318.0590
Equity:
Preferred Stock 00000000000000184.12562.43424.28116.2854
Common Stock 0.0030.0030.0030.0030.0030.0030.0030.0030.0020.0020.0020.0020.0020.0020.0020000
Retained Earnings -235.57-233.052-227.622-211.385-186.61-163.424-143.011-123.448-104.423-87.903-72.881-59.293-47.302-36.392-28.169-21.985-16.201-13.4070
Accumulated Other Comprehensive Income/Loss 00.1050-0.083-0.0330.237-0.195-0.223-0.201-0.466-0.771-0.785-0.644-0.059-184.125000-3.643
Other Total Stockholders Equity 310.613309.378308.112305.863277.544272.64268.926265.594217.717215.11212.788211.129209.891208.867392.1421.985-24.195-16.2220
Total Shareholders Equity 75.04676.43480.49394.39890.904109.456125.723141.926113.095126.743139.138151.053161.947172.418179.848-21.578-16.115-13.3440.357
Total Equity 75.04676.43480.49394.39890.904109.456125.723141.926113.095126.743139.138151.053161.947172.418179.848-21.578-16.115-13.3440.357
Total Liabilities & Shareholders Equity 77.53380.33290.959111.694106.821127.418140.876155.755124.393135.301147.656155.684166.999175.363184.12562.4349.9484.7150.357